Company Search:
Advanced Search
Sponsored Links
DiaMedica Therapeutics Inc Company Snapshot
DiaMedica Therapeutics Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares DiaMedica Therapeutics Inc with three other miscellaneous service companies in North America: Critical Outcome Technologies Inc. (2007 sales of 3,000.00 Canadian Dollars [US$2,392.35 ] ), Quest PharmaTech Inc (2,000.00 Canadian Dollars [US$1,594.90 ] ), and Northwest Biotherapeutics, Inc. which is based in the United States ($10,000.00 of which 100% was Immunotherapy Products).

Sales Analysis.
  Stock Performance Chart for DiaMedica Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): .27
(Figures in Canadian Dollars)
1 Week 1.9%   13 Weeks -1.8%  
4 Weeks -28.9%   52 Weeks 1.9%  
DiaMedica Therapeutics Inc Key Data:
  Ticker: DMA Country: United States
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2007 Sales 20,000
(Year Ending Jan 2008).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 32,698,964
  Fiscal Yr Ends: December Shares Outstanding: 121,107,275
  Share Type: Closely Held Shares: 23,009,200
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.